Back to results
CompletedPhase 3

Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

NCT02008357

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Alabama at Birmingham

Birmingham, Alabama, United States

+67 additional locations

View on ClinicalTrials.gov
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — TrialFind